Fig. 4

Impact of ICS on tumor burden as determined by bioluminescence measurements across all imaging sessions. Results are presented to compare the impact of ICS vs. no surgery alone (A) or combined with cisplatin administered on day 0 (B), 7 (C), and 28 (D). Points indicate the mean ± SEM. Data collected at each imaging time point were analyzed by ANOVA follow by Fisher LSD test, *p<0.05. Abbreviations are defined in the legend to Fig. 3